Microchip Q2 Earnings Beat Estimates, Sales Down Y/Y, Shares Drop

07.11.25 18:18 Uhr

Werte in diesem Artikel
Aktien

60,00 EUR 1,00 EUR 1,69%

Microchip Technology MCHP reported second-quarter fiscal 2026 non-GAAP earnings of 35 cents per share, which beat the Zacks Consensus Estimate by 6.06% but fell 24% year over year.Net sales of $1.14 billion decreased 2% year over year and beat the Zacks Consensus Estimate by 0.75%. Sequentially, revenues increased 6%.Following the fiscal second-quarter results, Microchip shares were down more than 9% at the time of writing this article. MCHP shares have inched up 3.5%, outperforming the broader Zacks Computer and Technology sector’s appreciation of 27.1% year to date.Microchip’s Segmental DetailsSales from Mixed-signal Microcontroller, Analog and Other accounted for 51.3%, 28.2% and 20.6% of net sales, respectively. Microcontroller grew 9.7% sequentially with strong contribution from 32-bit MCU, while analog business sales increased 1.7% sequentially.In terms of channel, direct sales accounted for 55%, while 45% came from distribution. Microchip Technology Incorporated Price, Consensus and EPS Surprise Microchip Technology Incorporated price-consensus-eps-surprise-chart | Microchip Technology Incorporated Quote Geographically, revenues from the Americas, Europe and Asia contributed 29.7%, 19.7% and 50.6% to net sales, respectively. Net sales grew in the Americas and Asia, while it was flat in Europe.MCHP’s Operating ResultsNon-GAAP gross margin contracted 290 basis points (bps) on a year-over-year basis to 56.7% but expanded 236 bps sequentially. Product gross margin was 67.4% driven by a rich product mix of data center products. Underutilization in MCHP’s factories in the reported quarter was $51 million.Non-GAAP research & development expenses, as a percentage of net sales, increased 170 bps year over year to 20.1%. Non-GAAP selling, general & administrative expenses, as a percentage of net sales, climbed 40 bps year over year to 12.3%.Non-GAAP operating expenses, as a percentage of net sales, were 32.4% compared with 30.3% reported in the year-ago quarter.Consequently, the non-GAAP operating margin declined to 24.3% compared with 29.3% reported in the year-ago quarter. Sequentially, operating margin expanded 364 bps.Microchip’s Balance Sheet & Cash FlowAs of Sept. 30, 2025, cash and short-term investments totaled $236.8 million compared with $566.5 million as of June 30. As of Sept. 30, 2025, total debt (long-term plus current portion) was $5.38 billion compared with $5.46 billion as of June.Inventory at the end of September 2025 was 199 days, down from 214 days at the end of June 2025. Distribution inventory days were reduced by a couple of days to 27 days.For the fiscal second quarter, cash flow from operating activities was $88.1 million compared with $275.6 million in the previous quarter. Free cash flow was $38.3 million compared with $257.7 million in the previous quarter.Microchip returned roughly $245.8 million to shareholders through dividends in the fiscal second quarter. The company announced a quarterly dividend of 45.5 cents per share.MCHP Offers Positive Q3 GuidanceMicrochip expects net sales to be $1.129 billion (+/-$20 million) at mid-point for the third quarter of fiscal 2026, which reflects roughly 1% sequential decline.The company expects inventory at the end of the September quarter to be between 195 and 200 days.Non-GAAP earnings are anticipated between 34 cents per share and 40 cents per share. Non-GAAP gross margin is anticipated between 57.2% and 59.2%. Non-GAAP operating expenses are projected to be 32.3-32.7%. Non-GAAP operating margin is anticipated to be 24.5-26.9%.Zacks Rank & Upcoming Earnings to ConsiderMicrochip currently carries a Zacks Rank #3 (Hold).Analog Devices ADI, CoreWeave CRWV and Exodus Movement EXOD are some better-ranked stocks worth considering in the broader Zacks Computer and Technology sector. While Exodus Movement currently sports a Zacks Rank #1, CoreWeave and Analog Devices carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.Exodus Movement shares are down 27.8% year to date. Exodus Movement is set to report its third-quarter 2025 results on Nov. 10.Analog Devices shares have appreciated 9.6% year to date. Analog Devices is set to report its fourth-quarter fiscal 2025 results on Nov. 25.CoreWeave shares have jumped 167.3% year to date. CoreWeave is set to report its third-quarter 2025 results on Nov. 10.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Analog Devices, Inc. (ADI): Free Stock Analysis Report Microchip Technology Incorporated (MCHP): Free Stock Analysis Report Exodus Movement, Inc. (EXOD): Free Stock Analysis Report CoreWeave Inc. (CRWV): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Q2 und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Q2

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q2

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Q2 Holdings Inc

Wer­bung

Analysen zu Q2 Holdings Inc

DatumRatingAnalyst
13.08.2019Q2 BuyCompass Point
01.03.2019Q2 BuyNeedham & Company, LLC
19.12.2018Q2 BuyBTIG Research
09.08.2018Q2 BuyNeedham & Company, LLC
11.05.2018Q2 NeutralBTIG Research
DatumRatingAnalyst
13.08.2019Q2 BuyCompass Point
01.03.2019Q2 BuyNeedham & Company, LLC
19.12.2018Q2 BuyBTIG Research
09.08.2018Q2 BuyNeedham & Company, LLC
16.02.2018Q2 BuyNeedham & Company, LLC
DatumRatingAnalyst
11.05.2018Q2 NeutralBTIG Research
18.11.2016Q2 Sector WeightPacific Crest Securities Inc.
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Q2 Holdings Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen